Möchten Sie immer auf dem neuesten Stand bleiben?

Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) --...

Harvard Bioscience Announces First Quarter 2026 Financial Results

TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- George Weston Limited (TSX: WN) (“GWL” or the “Company”) today announced its consolidated unaudited results for the 12 weeks ended March 28, 2026(2). ...

The Company achieved Q1 2026 record-breaking results across key metrics, including Paying Circles, Global Net Additions, and Subscription Revenue.

New York City, NY, May 08, 2026 (GLOBE NEWSWIRE) -- Let's start with something nobody in the snoring solutions industry wants to say out loud. Most anti-snoring products don't work. At least,...

Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Smart Grid Market: 2026 Edition" report has been added to ResearchAndMarkets.com's offering.The global smart grid market was valued at US$55.54 billion...

Strong start to year leads to second highest Q1 revenue in Company’s history.Advancement and completion of major projects drive Q1 revenue.Backlog of $43.1 million. MONTREAL, May 07, 2026 (GLOBE...

Reports Record First Quarter Revenue of $328.5 MillionEarly Selling Season Activity Reflects Robust Demand for Women's Health and Family Building SolutionsReturned Value to Shareholders Through...

Proceeds support commercialization of Arbli™, the first FDA-approved ready-to-use oral suspension for hypertension; and REZENOPY™, life-saving opioid overdose emergency treatment Financing also...

Total End of Period Subscribers of 2.7 million; End of Period Clinical Subscribers of 197 thousand, up 46% year-over-year Revenue of $168 million; Clinical Subscription Revenue of $39 million, up 32%...